Memphasys Ltd (MEM) - Product Pipeline Analysis, 2018 Update

Memphasys Ltd (MEM) - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME2283PD
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It serves therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Memphasys Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Memphasys Ltd Company Overview 4

Memphasys Ltd Company Snapshot 4

Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Memphasys Ltd-Pipeline Analysis Overview 6

Memphasys Ltd-Key Facts 6

Memphasys Ltd-Major Products and Services 7

Memphasys Ltd Pipeline Products by Development Stage 8

Memphasys Ltd Pipeline Products Overview 10

Felix 10

Felix Product Overview 10

Second Generation Clinical SpermSep Device 11

Second Generation Clinical SpermSep Device Product Overview 11

SpermSep200 12

SpermSep200 Product Overview 12

Memphasys Ltd-Key Competitors 13

Memphasys Ltd-Key Employees 14

Memphasys Ltd-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Memphasys Ltd, Recent Developments 16

Jul 19, 2018: Attendance at ESHRE Conference in Spain generates interest from selected, pre-eminent IVF clinics to conduct in-vitro studies with Felix device to demonstrate sperm separation efficacy 16

Jun 07, 2018: Memphasys Appoints Marjan Mikel as Non-Executive Director 16

May 03, 2018: Felix Device Development On-Track 16

Jun 29, 2017: Memphasys: Update On Spermsep Development 17

May 18, 2017: Memphasys Provides Update On Next Stage Of SPERMSEP Development 17

Aug 10, 2015: Start Of In-Vitro Clinical Trial At Monash IVF 18

Nov 29, 2013: NuSep Board Changes 19

Oct 29, 2013: NuSep Announces Board Changes 19

Sep 06, 2013: NuSep Presents at Bioplasma Conference 20

Aug 30, 2013: NuSep announces 30 June 2013 Full Year Results 20

Appendix 22

Methodology 22

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Figures

Memphasys Ltd Pipeline Products by Equipment Type 5

Memphasys Ltd Pipeline Products by Development Stage 8

List of Tables

Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Memphasys Ltd Pipeline Products by Equipment Type 5

Memphasys Ltd Pipeline Products by Indication 5

Memphasys Ltd, Key Facts 6

Memphasys Ltd, Major Products and Services 7

Memphasys Ltd Number of Pipeline Products by Development Stage 8

Memphasys Ltd Pipeline Products Summary by Development Stage 9

Felix-Product Status 10

Felix-Product Description 10

Second Generation Clinical SpermSep Device-Product Status 11

Second Generation Clinical SpermSep Device-Product Description 11

SpermSep200-Product Status 12

SpermSep200-Product Description 12

Memphasys Ltd, Key Employees 14

Glossary 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Factor Therapeutics Ltd

Regeneus Ltd

LBT Innovations Limited

Memphasys Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51908
Site License
USD 1,500 INR 69
Corporate User License
USD 2,250 INR 138



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]